Nomograms for Predicting the Overall and Cancer-Specific Survival of Patients with High-Grade Glioma: A Surveillance, Epidemiology, and End Results Study

被引:10
作者
Xia, Yuhan [1 ]
Liao, Weixin [2 ]
Huang, Shaozhuo [2 ]
Liu, Zhicheng [2 ]
Huang, Xiaowen [2 ]
Yang, Chen [2 ]
Ye, Chao [3 ]
Jiang, Yingjie [3 ]
Wang, Jun [2 ,4 ]
机构
[1] Southern Med Univ, Basic Med Coll, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Clin Med Sch 1, Guangzhou, Peoples R China
[3] Navy Med Univ, Basic Med Coll, 168 Changhai Rd, Shanghai, Peoples R China
[4] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Peoples R China
关键词
Brain tumors; Glioma; Nomogram; Overall survival; Cancer-specific survival; RADIATION-THERAPY; GLIOBLASTOMA; POPULATION; DIAGNOSIS; ONCOLOGY; TRIAL;
D O I
10.5137/1019-5149.JTN.26131-19.2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
AIM: To predict the overall survival (OS) and the cancer-specific survival (CSS) of patients with high-grade glioma (HGG) using nomograms and the surveillance, epidemiology, and end results (SEER) database (2000-2013). MATERIAL and METHODS: A total of 3706 patients with high-grade glioma were identified by the SEER database (2000-2013). Based on the relevant information of these patients, we divided the primary cohort into a training cohort (n=3336) and a validation cohort (n=370). The nomograms were constructed by the training cohort and corroborated by the validation cohort. RESULTS: According to the multivariate analysis of the training cohort, the nomograms of OS and CSS indicated that patient age at diagnosis, laterality, radiation, and the extent of resection are significantly correlated with the survival rate. The c-indexes of the nomograms of OS and CSS of the training cohort are 0.682 [95% confidence interval (CI): 0.671-0.693] and 0.678 (95%CI: 0.6660.690), respectively. The calibration curve plots of 1- and 3-year OS and CSS showed that the nomogram predictions are consistent with the observed outcomes for both the training and validation cohorts. CONCLUSION: Based on the data obtained, we established a scoring model to predict the OS and the CSS of patients with HGG. All calibration curves showed high consistency between the predicted and actual survival.
引用
收藏
页码:48 / 59
页数:12
相关论文
共 32 条
[1]  
Afra D, 2002, LANCET, V359, P1011
[2]   Nomograms in oncology: more than meets the eye [J].
Balachandran, Vinod P. ;
Gonen, Mithat ;
Smith, J. Joshua ;
DeMatteo, Ronald P. .
LANCET ONCOLOGY, 2015, 16 (04) :E173-E180
[3]   Racial/ethnic differences in survival among elderly patients with a primary glioblastoma [J].
Barnholtz-Sloan, Jill S. ;
Maldonado, John L. ;
Williams, Vonetta L. ;
Curry, William T. ;
Rodkey, Elizabeth A. ;
Barker, Frederick G., II ;
Sloan, Andrew E. .
JOURNAL OF NEURO-ONCOLOGY, 2007, 85 (02) :171-180
[4]   Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas [J].
Brandsma, Dieto ;
Stalpers, Lukas ;
Taal, Walter ;
Sminia, Peter ;
van den Bent, Martinj .
LANCET ONCOLOGY, 2008, 9 (05) :453-461
[5]   Marital status, treatment, and survival in patients with glioblastoma multiforme - A population-based study [J].
Chang, SM ;
Barker, FG .
CANCER, 2005, 104 (09) :1975-1984
[6]   Evaluating the prognostic factors effective on the outcome of patients with glioblastoma multiformis: does maximal resection of the tumor lengthen the median survival? [J].
Faramarz-Allandini ;
Amirjamshidi, Abbass ;
Reza-Zarei, Mohammad ;
Abdollahi, Morteza .
WORLD NEUROSURGERY, 2010, 73 (02) :128-134
[7]   Prognostic factors for glioblastoma patients - a clinical population-based study [J].
Fekete, B. ;
Werlenius, K. ;
Orndal, C. ;
Rydenhag, B. .
ACTA NEUROLOGICA SCANDINAVICA, 2016, 133 (06) :434-441
[8]   Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3 [J].
Gorlia, Thierry ;
van den Bent, Martini ;
Hegi, Monika E. ;
Mirimanoff, Rene O. ;
Weller, Michael ;
Cairncross, J. Gregory ;
Eisenhauer, Elizabeth ;
Belanger, Karl ;
Brandes, Alba A. ;
Allgeier, Anouk ;
Lacombe, Denis ;
Stupp, Roger .
LANCET ONCOLOGY, 2008, 9 (01) :29-38
[9]  
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO
[10]  
2-4